Mesoblast LimitedASX: MSB

Mesoblast 2026 Full Year Financial Results Webcast

· Issued by Mesoblast Limited via ASX

Filed with ASX ·

MESOBLAST FINANCIAL RESULTS AND CORPORATE UPDATE WEBCAST New York, USA, and Melbourne, Australia: August 24, 2026 : Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and...

View Attachment

6ix hasn’t read this filing yet.

Mesoblast Limited on 6ix

In the deck

Story so far

Earlier from Mesoblast

Later from Mesoblast

All Mesoblast news releases